FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2465962037> ?p ?o ?g. }

• W2465962037 abstract "Multiple myeloma, the second most common haematological cancer, remains incurable. Its incidence is rising due to population ageing. Despite the impact of the disease and its treatment, not much is known on who is most in need of supportive and palliative care. This study aimed to (a) assess symptom severity, palliative care concerns and health-related quality of life (HRQOL) in patients with multiple myeloma, and (b) to determine which factors are associated with a lower quality of life. We further wanted to know (c) whether general symptom level has a stronger influence on HRQOL than disease characteristics.This multi-centre cross-sectional study sampled two cohorts of patients with multiple myeloma from 18 haematological cancer centres in the UK. The Myeloma Patient Outcome Scale (MyPOS) was used to measure symptoms and concerns. Measures of quality of life included the EORTC QLQ-C30, its myeloma module and the EuroQoL EQ-5D. Data were collected on socio-demographic, disease and treatment characteristics and phase of illness. Point prevalence of symptoms and concerns was determined. Multiple regression models quantified relationships between independent factors and the MyPOS, EORTC global quality of life item and EQ5D Index.Five-hundred-fifty-seven patients, on average 3.5 years (SD: 3.4) post-diagnosis, were recruited. 18.2 % had newly diagnosed disease, 47.9 % were in a treatment-free interval and 32.7 % had relapsed/progressive disease phase. Patients reported a mean of 7.2 symptoms (SD: 3.3) out of 15 potential symptoms. The most common symptoms were pain (72 %), fatigue (88 %) and breathlessness (61 %). Those with relapsed/progressive disease reported the highest mean number of symptoms and the highest overall palliative care concerns (F = 9.56, p < 0.001). Factors associated with high palliative care concerns were a general high symptom level, presence of pain, anxiety, low physical function, younger age, and being in the advanced stages of disease.Patients with multiple myeloma have a high symptom burden and low HRQOL, in the advanced and the earlier stages of disease. Identification of patients in need of supportive care should focus on assessing patient-reported outcomes such as symptoms and functioning regularly in clinical practice, complementary to traditional biomedical markers." @default.
• W2465962037 created "2016-07-22" @default.
• W2465962037 creator A5011369109 @default.
• W2465962037 creator A5020357934 @default.
• W2465962037 creator A5023182189 @default.
• W2465962037 creator A5051570372 @default.
• W2465962037 creator A5085758009 @default.
• W2465962037 creator A5089547051 @default.
• W2465962037 creator A5091519589 @default.
• W2465962037 date "2016-07-07" @default.
• W2465962037 modified "2023-10-12" @default.
• W2465962037 title "The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study" @default.
• W2465962037 cites W1534149600 @default.
• W2465962037 cites W1845447069 @default.
• W2465962037 cites W1933522958 @default.
• W2465962037 cites W1965607454 @default.
• W2465962037 cites W1966689896 @default.
• W2465962037 cites W1967013046 @default.
• W2465962037 cites W1970681172 @default.
• W2465962037 cites W1970753621 @default.
• W2465962037 cites W1987138256 @default.
• W2465962037 cites W1989136584 @default.
• W2465962037 cites W1997057673 @default.
• W2465962037 cites W1998628488 @default.
• W2465962037 cites W1998652599 @default.
• W2465962037 cites W1999307871 @default.
• W2465962037 cites W2005979739 @default.
• W2465962037 cites W2018327989 @default.
• W2465962037 cites W2024557769 @default.
• W2465962037 cites W2034449817 @default.
• W2465962037 cites W2039234480 @default.
• W2465962037 cites W2044436186 @default.
• W2465962037 cites W2051391635 @default.
• W2465962037 cites W2054163626 @default.
• W2465962037 cites W2056881595 @default.
• W2465962037 cites W2066421899 @default.
• W2465962037 cites W2066711828 @default.
• W2465962037 cites W2066800926 @default.
• W2465962037 cites W2069189915 @default.
• W2465962037 cites W2072018052 @default.
• W2465962037 cites W2075135525 @default.
• W2465962037 cites W2076668534 @default.
• W2465962037 cites W2087484885 @default.
• W2465962037 cites W2089945456 @default.
• W2465962037 cites W2090063312 @default.
• W2465962037 cites W2090247445 @default.
• W2465962037 cites W2092701398 @default.
• W2465962037 cites W2093783112 @default.
• W2465962037 cites W2095255742 @default.
• W2465962037 cites W2099077086 @default.
• W2465962037 cites W2106130415 @default.
• W2465962037 cites W2106545856 @default.
• W2465962037 cites W2113604545 @default.
• W2465962037 cites W2118975628 @default.
• W2465962037 cites W2120474651 @default.
• W2465962037 cites W2120680348 @default.
• W2465962037 cites W2136310122 @default.
• W2465962037 cites W2144096524 @default.
• W2465962037 cites W2148011420 @default.
• W2465962037 cites W2161628140 @default.
• W2465962037 cites W2162772535 @default.
• W2465962037 cites W2164667231 @default.
• W2465962037 cites W2166281097 @default.
• W2465962037 cites W2167571044 @default.
• W2465962037 cites W2169231929 @default.
• W2465962037 cites W2169961966 @default.
• W2465962037 cites W2219978888 @default.
• W2465962037 cites W2473786944 @default.
• W2465962037 cites W4211135634 @default.
• W2465962037 cites W4246147341 @default.
• W2465962037 cites W4292024189 @default.
• W2465962037 doi "https://doi.org/10.1186/s12885-016-2410-2" @default.
• W2465962037 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4937527" @default.
• W2465962037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27387201" @default.
• W2465962037 hasPublicationYear "2016" @default.
• W2465962037 type Work @default.
• W2465962037 sameAs 2465962037 @default.
• W2465962037 citedByCount "99" @default.
• W2465962037 countsByYear W24659620372017 @default.
• W2465962037 countsByYear W24659620372018 @default.
• W2465962037 countsByYear W24659620372019 @default.
• W2465962037 countsByYear W24659620372020 @default.
• W2465962037 countsByYear W24659620372021 @default.
• W2465962037 countsByYear W24659620372022 @default.
• W2465962037 countsByYear W24659620372023 @default.
• W2465962037 crossrefType "journal-article" @default.
• W2465962037 hasAuthorship W2465962037A5011369109 @default.
• W2465962037 hasAuthorship W2465962037A5020357934 @default.
• W2465962037 hasAuthorship W2465962037A5023182189 @default.
• W2465962037 hasAuthorship W2465962037A5051570372 @default.
• W2465962037 hasAuthorship W2465962037A5085758009 @default.
• W2465962037 hasAuthorship W2465962037A5089547051 @default.
• W2465962037 hasAuthorship W2465962037A5091519589 @default.
• W2465962037 hasBestOaLocation W24659620371 @default.
• W2465962037 hasConcept C120665830 @default.
• W2465962037 hasConcept C121332964 @default.
• W2465962037 hasConcept C121608353 @default.
• W2465962037 hasConcept C126322002 @default.
• W2465962037 hasConcept C159110408 @default.
• W2465962037 hasConcept C1862650 @default.

• next